The PDGF (14) , of the A chain in human fibroblasts (8) , and of both chains in endothelial cells (15) . The mitogenic activity of interleukin 1 (IL-1) in smooth muscle cells is mediated by an induced PDGF-AA (16) . PDGF induces the expression of PDGF A chain mRNA and protein in human fibroblasts, suggesting a positive autocrine feedback mechanism in growth regulation (8) . Similar obser¬ vations have also been made with regard to autoin¬ duction of TGF-cc (17) and TGF-ß (18) .
The isoforms of PDGF bind with different affinities to two structurally related receptors
Receptors for PDGF were initially discovered on mesenchymal and glial cells, using PDGF purified from human platelets. Such preparations are now known to consist of both PDGF-AB and PDGF-BB.
The standard protocol for I2:,I-labelling of such PDGF involved the use of chloramine T which only tags tyrosine residues, present on A but not on B chains; thus, the effective ligand in these binding studies was 125I-PDGF-AB. The availability of recombinant PDGF recently made it possible to study the binding of all isoforms of PDGF. Given our finding that the different isoforms of PDGF were not equally potent in cultured human foreskin fibroblasts (19) , such an approach was considered important. Cross-competition studies showed that there actually exist two types of PDGF receptors, denoted a and ß (20, 21) , (the terminology type A and type B receptors has also been used). These receptors differ in ligand binding specificity in that the ci-receptor binds all three isoforms with high and about equal affinities, whereas the ß-receptor only binds PDGF-BB with a similarly high affinity.
The latter receptor type binds PDGF-AB with about ten-fold lower affinity and does not appear to recognize PDGF-AA with any measurable affinity.
The PDGF receptors are protein tyrosine kinases
Early studies on the PDGF receptor, now known to be identical to the ß-receptor, showed that it pos¬ sesses a ligand-stimulatable protein-tyrosine kinase activity (22) . Recent studies have shown that also the a-receptor has this function (23, 24) . One In an elegant study Heldin and collaborators (32) showed that purified PDGF ß-receptor is dimerized when challenged with its ligand. Receptor dimerization was found to be intimately linked to activa- (37) (38) (39) .
A putative substrate for the PDGF receptor kinase is the enzyme phosphatidylinositol 3' kinase, which phosphorylates the D-3 position of phosphatidylinositols (40, 41) . This reaction yields precursor molecules for a family of novel inositol phosphates, the role of which in signal transduction remains to be elucidated. It should be noted that the pho¬ sphatidylinositol 3' kinase is also activated by the pp60cs'7polyoma middle T complex (42, 43) and thus may be involved in cell transformation.
A GTPase-activating protein has been identified as a substrate for the activated PDGF receptor (44, 45 (49) .
The phenomena of density-dependent inhibi¬ tion and cellular senescence are thought to reflect basic growth control mechanisms that are often out of order in transformed cells. The finding that these phenomena can be studied at the level of growth factor activity provides a hope for future attempts to elucidate their molecular mechanisms.
As we are making progress in the understanding of the signal transduction pathways of PDGF and other growth factors, we may be able to identify the block that makes the cells refractory. An interesting finding along these lines is that transforming growth factor-ß augments the effect of cell density on cell proliferation (50 (59) . Experimental data have shown that the transforming activity of the v-sis product re¬ quires a hydrophobic leader sequence (60) . Experiments on the metabolic processing of p2gsis have shown that it is converted to a stable dimer of 24 kD (61), which is structurally homol¬ ogous to a truncated form of PDGF-BB. However, the 24 kD product does not behave as a classically secreted protein but to a large extent remains as¬ sociated with the cell (62) . Experiments with transfected Chinese hamster ovary cells stably express¬ ing PDGF-A and PDGF-B have shown that PDGF-AA, PDGF-AB and 30-kD form of PDGF-BB are secreted, whereas the 24-kD PDGF-BB species is retained (63) . The precise molecular structure of the latter form of PDGF-BB remains to be eluci¬ dated, as well as the mechanisms whereby it is gen¬ erated and retained.
There is ample evidence that transformation by the v-sis oncogene occurs by an autocrine mecha¬ nism: the sis gene encodes a PDGF-like growth factor that binds to and activates the cell's own re¬ ceptor. The subcellular location at which the v-sis product interacts with the PDGF receptor, how¬ ever, has not yet been unequivocally defined. Sev¬ eral investigators have suggested that the autocrine growth factor activates the receptor in an intracellular compartment. There is indeed convincing ev-idence that the protein tyrosine kinase activity of an intracellular PDGF receptor is constitutively active in sis-transformed cells (64) (65) . Moreover, a recombinant v-sis protein endowed with a C-terminal retention signal has the same transforming activity as the native form of the protein (67) . The latter result is, however, ambiguous since the experi¬ ments did not account for the possibility of leakage of the recombinant protein through the secretory system. Several studies, on the other hand, indicate that the mitogenic signal, leading to cell transfor¬ mation, is generated at the cell surface. Thus, PDGF antibodies attenuate simian sarcoma virustransformation of human diploid fibroblasts and inhibit their growth in serum-free medium (68) . In addition, the transformed phenotype of simian sar¬ coma virus-transformed cells is completely re¬ versed by the addition of suramin (69) (70) who found that inhibition of the intracellular transport of the v-sis product had no effect on the autophosphorylation of the intracellular PDGF re¬ ceptor, but blocked the stimulatory effect on c-fos expression. Our interpretation of all these experi¬ ments is that the v-sis product interacts with PDGF receptors intracellularly, but for the mitogenic signal to be generated the ligand-receptor complex has to be presented at the plasma membrane, pos¬ sibly to be able to interact with the proper sub¬ strates for the receptor-associated protein tyrosine (72) .
In situ hybridization of glioma tissue has shown that PDGF is also expressed in primary gliomas (73) (81) . The system is specifically regulated by PDGF-AA and the 0-2A cells seem to express a-receptors only (82 
